Outfitter Financial’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-6,970
Closed -$466K 83
2024
Q3
$466K Sell
6,970
-240
-3% -$22K 0.38% 70
2024
Q2
$856K Sell
7,210
-570
-7% -$72.1K 0.71% 48
2024
Q1
$829K Sell
7,780
-70
-0.9% -$7.06K 0.68% 53
2023
Q4
$781K Buy
+7,850
New +$660K 0.68% 51
2022
Q1
Sell
-125
Closed -$32K 172
2021
Q4
$32K Buy
+125
New +$36.5K 0.02% 127

Other funds holding MRNA

Outfitter Financial's MRNA Position: Q4 2024 in Review

Outfitter Financial sold out of Moderna (MRNA) in Q4 2024, closing a stake of 6,970 shares — an estimated $466K sold.

Outfitter Financial first reported a position in MRNA in Q4 2021 and held it in 5 quarters. The position peaked at $856K in Q2 2024. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • Outfitter Financial reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • Outfitter Financial sold 6,970 Moderna shares in Q4 2024, an estimated $466K.
  • Outfitter Financial first reported a position in Moderna in Q4 2021 and held it in 5 quarters.
  • Outfitter Financial's Moderna position peaked at $856K in Q2 2024.
  • 745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on Outfitter Financial's 13F filing for Q4 2024, filed 3 Feb 2025.